Curie AI has developed a patented passive monitoring technology for recognizing the respiratory symptoms patients experience while sleeping. It is delivered through a simple user interface that results in a 98% adherence to daily usage. Our Actionable Insights engine then delivers the most accurate insights from the monitoring data to the clinical team in order to provide personalized proactive care for every patient.
Our passive contactless monitoring technology has 14 patents allowing for ease of use and 98% adherence resulting in more actionable insights. With the world’s largest respiratory biomarker dataset of over 1 million hours, our AI will deliver the most accurate and actionable insights to our clinical team to create and proactively adjust the best possible treatment plan. Our skilled respiratory clinicians have every patient's current and historical data at their fingertips right in the Curie AI dashboard. With the ability to use this data and AI insights, our clinicians can message or video chat directly with patients to deliver a truly personalized experience. Proactive care leads to fewer exacerbations and a better quality of life.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2C
Company Size: 26 to 50
Founded: 2018
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Curie AI
Navya Davuluri
Founder, CEO
Sridhar Nemala
Co-Founder and Head of AI
Ravi Yalamanchili
Co-Founder, Head of engineering